Engineered extracellular vesicles for concurrent Anti-PDL1 immunotherapy and chemotherapy.

Bioact Mater · 2022 · PMC8586263 · PMID 34820569

Europe PMC DOI

hedged sentence

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

close to being statistically significantp > 0.05actually significant

The difference in tumor volume was very close to being statistically significant (ANOVA, p > 0.05).

also in 228 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.